188 related articles for article (PubMed ID: 31272697)
1. Genetic risk for coronary heart disease alters the influence of Alzheimer's genetic risk on mild cognitive impairment.
Elman JA; Panizzon MS; Logue MW; Gillespie NA; Neale MC; Reynolds CA; Gustavson DE; Rana BK; Andreassen OA; Dale AM; Franz CE; Lyons MJ; Kremen WS
Neurobiol Aging; 2019 Dec; 84():237.e5-237.e12. PubMed ID: 31272697
[TBL] [Abstract][Full Text] [Related]
2. Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
Liu H; Lutz M; Luo S;
J Alzheimers Dis; 2021; 84(3):1323-1335. PubMed ID: 34657885
[TBL] [Abstract][Full Text] [Related]
3. A polygenic risk score for Alzheimer's disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic/Latino adults in the U.S.
Sofer T; Kurniansyah N; Granot-Hershkovitz E; Goodman MO; Tarraf W; Broce I; Lipton RB; Daviglus M; Lamar M; Wassertheil-Smoller S; Cai J; DeCarli CS; Gonzalez HM; Fornage M
Alzheimers Res Ther; 2023 Aug; 15(1):146. PubMed ID: 37649099
[TBL] [Abstract][Full Text] [Related]
4. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease.
Liu H; Lutz M; Luo S;
J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1734-1742. PubMed ID: 35797594
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
6. Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s.
Logue MW; Panizzon MS; Elman JA; Gillespie NA; Hatton SN; Gustavson DE; Andreassen OA; Dale AM; Franz CE; Lyons MJ; Neale MC; Reynolds CA; Tu X; Kremen WS
Mol Psychiatry; 2019 Mar; 24(3):421-430. PubMed ID: 29487403
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
Leonenko G; Shoai M; Bellou E; Sims R; Williams J; Hardy J; Escott-Price V;
Ann Neurol; 2019 Sep; 86(3):427-435. PubMed ID: 31199530
[TBL] [Abstract][Full Text] [Related]
8. Distribution of 54 polygenic risk scores for common diseases in long lived individuals and their offspring.
Gunn S; Wainberg M; Song Z; Andersen S; Boudreau R; Feitosa MF; Tan Q; Montasser ME; O'Connell JR; Stitziel N; Price N; Perls T; Schork NJ; Sebastiani P
Geroscience; 2022 Apr; 44(2):719-729. PubMed ID: 35119614
[TBL] [Abstract][Full Text] [Related]
9. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
10. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
Femminella GD; Harold D; Scott J; Williams J; Edison P;
J Alzheimers Dis; 2021; 79(1):127-139. PubMed ID: 33216025
[TBL] [Abstract][Full Text] [Related]
11. From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.
Harrison JR; Mistry S; Muskett N; Escott-Price V
J Alzheimers Dis; 2020; 74(4):1271-1283. PubMed ID: 32250305
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of genetic difference between mild cognitive impairment and Alzheimer's disease through genome-wide association study].
Bai Z; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):342-346. PubMed ID: 29896728
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
[No Abstract] [Full Text] [Related]
14. Characterization of brain resilience in Alzheimer's disease using polygenic risk scores and further improvement by integrating mitochondria-associated loci.
Xu X; Wang H; Bennett DA; Zhang QY; Meng XY; Zhang HY
J Adv Res; 2024 Feb; 56():113-124. PubMed ID: 36921896
[TBL] [Abstract][Full Text] [Related]
15. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
16. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
Rodríguez-Rodríguez E; Sánchez-Juan P; Vázquez-Higuera JL; Mateo I; Pozueta A; Berciano J; Cervantes S; Alcolea D; Martínez-Lage P; Clarimón J; Lleó A; Pastor P; Combarros O
J Neural Transm (Vienna); 2013 May; 120(5):807-12. PubMed ID: 23180304
[TBL] [Abstract][Full Text] [Related]
17. Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
Gabriel AJ; Almeida MR; Ribeiro MH; Carneiro D; Valério D; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
J Alzheimers Dis; 2018; 61(3):1097-1105. PubMed ID: 29254094
[TBL] [Abstract][Full Text] [Related]
18. Computational Modeling of the n-Back Task in the ABCD Study: Associations of Drift Diffusion Model Parameters to Polygenic Scores of Mental Disorders and Cardiometabolic Diseases.
Pedersen ML; Alnæs D; van der Meer D; Fernandez-Cabello S; Berthet P; Dahl A; Kjelkenes R; Schwarz E; Thompson WK; Barch DM; Andreassen OA; Westlye LT
Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Mar; 8(3):290-299. PubMed ID: 35427796
[TBL] [Abstract][Full Text] [Related]
19. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
[TBL] [Abstract][Full Text] [Related]
20. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
